ATAD2B and cancer: HDAC3, HDAC10, HDAC2, HDAC7, ATAD2B were significantly upregulated in 9, 14, 13, 9, and 10 cancer types, respectively, whereas KAT2B was downregulated in 16 cancer types (Fig. 2A and Table S3).